Transcription elongation factor A1 pseudogene 3 (TCEA1P3)

Transcription elongation factor A1 pseudogene 3 (TCEA1P3) is a non-protein-coding genomic sequence classified as a pseudogene of the TCEA1 gene, which encodes the transcription elongation factor A1. Unlike its parent gene, TCEA1P3 does not produce a functional protein. Pseudogenes like TCEA1P3 are generally remnants of once-functional genes and do not have established physiological or disease roles, nor are they recognized as therapeutic targets. TCEA1P3 is not known to be involved in any canonical molecular process or to interact with drugs, serve as a biomarker, or pose documented safety concerns[2]. Key contextual points: - The *TCEA1* gene encodes a well-characterized transcription elongation factor but *TCEA1P3* is a *pseudogene*, not a functional gene or established target[2]. - This pseudogene does not code for a protein and is not implicated in drug targeting, diagnostics, or therapeutics. - Pseudogenes can sometimes generate non-coding RNA with regulatory potential, but there is no specific evidence or publication indicating TCEA1P3 is functionally relevant in biology or disease[2]. - There is no research or data supporting the use of TCEA1P3 as a therapeutic or diagnostic target, nor does it fit known molecular target classifications. - The query may be *incorrect or misleading* if it assumes TCEA1P3 is a bona fide molecular target, druggable protein, or disease gene. If you intended to refer to the functional *TCEA1* (transcription elongation factor A1), or another transcription elongation factor, please clarify as these are functionally significant proteins[4], but TCEA1P3 is not.

Other names

TCEA1P3TCEA1 pseudogene 3